Early prediction of autoimmune (type 1) diabetes.
Open accessThe DOI matches its Crossref record; 127 of the 127 references it cites were found in a registry or an index.
Abstract
Underlying type 1 diabetes is a genetic aetiology dominated by the influence of specific HLA haplotypes involving primarily the class II DR-DQ region. In genetically predisposed children with the DR4-DQ8 haplotype, exogenous factors, yet to be identified, are thought to trigger an autoimmune reaction against insulin, signalled by insulin autoantibodies as the first autoantibody to appear. In children with the DR3-DQ2 haplotype, the triggering reaction is primarily against GAD signalled by GAD autoantibodies (GADA) as the first-appearing autoantibody. The incidence rate of insulin autoantibodies as the first-appearing autoantibody peaks during the first years of life and declines thereafter. The incidence rate of GADA as the first-appearing autoantibody peaks later but does not decline. The first autoantibody may variably be followed, in an apparently non-HLA-associated pathogenesis, by a second, third or fourth autoantibody. Although not all persons with a single type of autoantibody progress to diabetes, the presence of multiple autoantibodies seems invariably to be followed by loss of functional beta cell mass and eventually by dysglycaemia and symptoms. Infiltration of mononuclear cells in and around the islets appears to be a late phenomenon appearing in the multiple-autoantibody-positive with dysglycaemia. As our understanding of the aetiology and pathogenesis of type 1 diabetes advances, the improved capability for early prediction should guide new strategies for the prevention of type 1 diabetes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
![Fig. 1 Proposed staging of type 1 diabetes. The aetiology is represented by a variable genetic and environmental risk. The pathogenesis is represented by three stages. In stage 1, beta cell autoantibodies are persistent, normoglycaemia prevails and there are no symptoms. During stage 2, the number of beta cell autoantibodies may affect the pathogenesis to induce dysglycaemia but there are still no diabetes symptoms. In stage 3, beta cell autoantibodies are still prevalent (some of them may have been lost) and there are symptoms of diabetes. The staging of type 1 diabetes pathogenesis was proposed by Insel et al [1] and the figure is adapted with permission from Insel et al [1]. © 2015 The American Diabetes Association](https://figures.cochat.ai/paper-figures/ec2c0c7eba0c42db9615a6352c9e3db7/early-prediction-of-autoimmune-type-1-diabetes-figure-1.jpg)

Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Although the prevalence of several autoantibodies associated with T1DM tends to decrease with increasing age at diagnosis61, GADA remains the dominant autoantibody in adult-onset T1DM regardless of ethnicity62–64.”
From The epidemiology of type 1 diabetes mellitus in older adults (2025) · cites this paper as [61]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Approximately twice as many women are diagnosed with gestational diabetes using the IADPSG criteria compared with the Carpenter-Coustan criteria.6”
From Association of Gestational Diabetes With Maternal Disorders of Glucose Metabolism and Childhood Adiposity (2018) · cites this paper as [6]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“The risk factors for progression to type 2 diabetes include maternal age, prepartum and postpartum BMI, family history of type 2 diabetes, receipt of insulin for gestational diabetes, and fasting glucose level during pregnancy.6,[24][25][26]”
From Association of Gestational Diabetes With Maternal Disorders of Glucose Metabolism and Childhood Adiposity (2018) · cites this paper as [6]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease
Ueda, H., Howson, J. M. M., Esposito, L., Heward, J., Snook, Chamberlain, G., Rainbow, D. B., Hunter, K. M. D., Smith, A. N., Di Genova, G., et al. (2003) · Nature · doi:10.1038/nature01621 · Cited by 2,175 · cited 1×
“Many of these genes are implicated in immune system regulation in particular and beta cell function less often [38, 39].”
BackgroundSeroconversion to multiple islet autoantibodies and risk of progression to diabetes in children
Ziegler, A. G., Rewers, M., Simell, O., Simell, T., Lempainen, J., Steck, A., Winkler, C., Ilonen, J., Veijola, R., Knip, M., et al. (2013) · JAMA · doi:10.1001/jama.2013.6285 · Cited by 1,312
Insel, R. A., Dunne, J. L., Atkinson, M. A., Chiang, J. L., Dabelea, D., Gottlieb, P. A., Greenbaum, C. J., Herold, K. C., Krischer, J. P., Lernmark, Å., et al. (2015) · Diabetes Care · doi:10.2337/dc15-1419 · Cited by 1,216 · cited 1×
“The staging of type 1 diabetes pathogenesis was proposed by Insel et al [1] and the figure is adapted with permission from Insel et al [1].”
MethodSelf-citationIncidence of childhood type 1 diabetes worldwide. Diabetes Mondiale (DiaMond) Project Group
Karvonen, M., Viik-Kajander, M., Moltchanova, E., Libman, I., LaPorte, R., & Tuomilehto, J. (2000) · Diabetes Care · doi:10.2337/diacare.23.10.1516 · Cited by 1,072
Type 1 Diabetes: Etiology, Immunology, and Therapeutic Strategies
Van Belle, T. L., Coppieters, K. T., & Von Herrath, M. G. (2011) · Physiological Reviews · doi:10.1152/physrev.00003.2010 · Cited by 1,022 · cited 1×
“Beta cell autoantibodies, long regarded as merely markers of the autoimmune process, may contribute through B cells presenting antigens to CD4 and CD8 T cells [79].”
BackgroundThe role of inflammation in insulitis and β-cell loss in type 1 diabetes
Eizirik, D. L., Colli, M. L., & Ortis, F. (2009) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2009.21 · Cited by 1,011 · cited 1×
“Although B and Tcell activity is a known key driver of beta cell destruction, the role of the innate immune system in type 1 diabetes is also recognised [86].”
BackgroundType 1 Diabetes Through the Life Span: A Position Statement of the American Diabetes Association
Chiang, J. L., Kirkman, M. S., Laffel, L. M. B., Peters, A. L., & Authors, O. B. O. T. T. 1. D. S. (2014) · Diabetes Care · doi:10.2337/dc14-1140 · Cited by 965
β-Cell death during progression to diabetes
Mathis, D., Vence, L., & Benoist, C. (2001) · Nature · doi:10.1038/414792a · Cited by 884
HLA DR-DQ Haplotypes and Genotypes and Type 1 Diabetes Risk
Erlich, H., Valdes, A. M., Noble, J., Carlson, J. A., Varney, M., Concannon, P., Mychaleckyj, J. C., Todd, J. A., Bonella, P., Fear, A. L., et al. (2008) · Diabetes · doi:10.2337/db07-1331 · Cited by 790 · cited 1×
“5% of individuals with and without type 1 diabetes, respectively [25].”
BackgroundMajor Histocompatibility Complex Genomics and Human Disease
Trowsdale, J., & Knight, J. C. (2013) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev-genom-091212-153455 · Cited by 759 · cited 2×
“The HLA class III region is genetically dense and codes for several proteins important to the immune system, such as complement factors and TNF-α [12].”
Background
Cited by
Lowe, W. L., Scholtens, D. M., Lowe, L. P., Kuang, A., Nodzenski, M., Talbot, O., Catalano, P. M., Linder, B., Brickman, W. J., Clayton, P., et al. (2018) · JAMA · doi:10.1001/jama.2018.11628 · Cited by 591
“Therewere4motherswithdiabeteswhowereexcludedbased onantibodies consistentwith type 1diabetes.(7)Prediabeteswas”
Chen, B., Yu, P., Chan, W. N., Xie, F., Zhang, Y., Liang, L., Leung, K. T., Lo, K. W., Yu, J., Tse, G. M. K., et al. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01679-y · Cited by 420
“228 231 Furthermore, ZnT8 autoantibodies are detected in approximately 60 – 80% of new cases that are clinically con fi rmed as being affected by type 1 diabetes within the patient population.”
BackgroundTargeted Elimination of Senescent Beta Cells Prevents Type 1 Diabetes
Thompson, P. J., Shah, A., Ntranos, V., Van Gool, F., Atkinson, M., & Bhushan, A. (2019) · Cell Metabolism · doi:10.1016/j.cmet.2019.01.021 · Cited by 353
Subtypes of Type 2 Diabetes Determined From Clinical Parameters
Ahlqvist, E., Prasad, R. B., & Groop, L. (2020) · Diabetes · doi:10.2337/dbi20-0001 · Cited by 229
“Type 1 diabetes (T1D) and latent autoimmune diabetes of the adult (LADA) both result from autoimmune destruction of b-cells, often, but not always, reflected by presence of pancreatic autoantibodies in the blood that can be used as a diagnostic marker (3).”
BackgroundDiagnosis and treatment of type 1 diabetes at the dawn of the personalized medicine era
Akil, A. A.-S., Yassin, E., Al-Maraghi, A., Aliyev, E., Al-Malki, K., & Fakhro, K. A. (2021) · Journal of Translational Medicine · doi:10.1186/s12967-021-02778-6 · Cited by 168
Metadata
- Authors
- Regnell, S. E., & Lernmark, Å.
- Affiliations
- Lund University (SE)
- Corresponding author
- Lernmark, Åke
- Venue
- Diabetologia
- Published
- 2017-05-26
- Volume
- 60
- Issue
- 8
- Pages
- 1370-1381
- ISSN
- 0012-186X (ISSN-L)
- 1432-0428
- PMC
- PMC5491594
- OpenAlex
- W2620432821
- Cited by
- 195
- References
- 127
- Citations by year
- 2026: 8 · 2025: 12 · 2024: 16 · 2023: 26 · 2022: 30 · 2021: 41 · 2020: 20 · 2019: 20 · 2018: 17 · 2017: 5
- FWCI
- 2.19
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Locations
- Diabetologia (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Lund University Publications (Lund University) (submittedVersion)
- Funders
- Lund University
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Diabetes and associated disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Keywords
- type 1 diabetes, early prediction, insulin autoantibodies, glutamic acid decarboxylase antibodies, HLA-DQ8, HLA-DQ2, HLA class II, beta-cell mass loss, islet infiltration, mononuclear cell infiltration, type 1 diabetes prevention, genetic susceptibility
- MeSH terms
- Autoantibodies, Child, Diabetes Mellitus, Type 1, Female, Glutamate Decarboxylase, Humans, Insulin Antibodies, Male
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Early prediction of autoimmune (type 1) diabetes. https://app.cochat.ai/papers/10.1007/s00125-017-4308-1
- The paper
- Regnell, S. E., & Lernmark, Å. (2017). Early prediction of autoimmune (type 1) diabetes. Diabetologia. https://doi.org/10.1007/s00125-017-4308-1
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.